Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Oregon Health & Science University, Portland, OR 97239, USA. lsperoff@msn.com
The most important unanswered question regarding postmenopausal hormone therapy and the risk of breast cancer is whether hormone therapy initiates the growth of new breast cancers or whether the epidemiologic data reflect a hormonal impact on preexisting tumors. In this perspective I review the evidence favoring hormonal effects on preexisting tumors and suggest that exposure to combined estrogen and progestin is beneficial, causing greater differentiation and earlier detection of breast cancers.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on